A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration.

The cause for the normal calcemic response to exogenous parathyroid hormone (PTH) was explored in a case of pseudohypoparathyroidism. The diagnosis of pseudohypoparathyroidism in this 29-yr-old woman was well established, since she had hypocalcemia (6.6 mg/dl), hyperphosphatemia (5.0 mg/ dl), high serum immunoreactive PTH, and negligible urinary cAMP response to exogenous PTH. Treatment with Amphojel slightly increased serum calcium (to 7.4 mg/dl) and lowered serum phosphorus (to 4.1 mg/dl) without altering the serum concentration of 1 alpha, 25-dihydroxyvitamin D [1,25(OH)2D]. After im administration of parathyroid extract (400 U/day for 4 days), serum calcium increased to 9.2 mg/dl, commensurate with significant elevations in serum 1,25(OH)2D (from 1.2 to 2.6 ng/dl) and fractional (intestinal) calcium absorption (from 0.22 to 0.43). The results suggest that the synthesis of 1,25(OH)2D upon PTH challenge was relatively intact and may have accounted for the normal calcemic response.

[1]  C. Pak,et al.  Evaluation of calcium urolithiasis in ambulatory patients: comparison of results with those of inpatient evaluation. , 1978, The American journal of medicine.

[2]  M. Haussler,et al.  Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone. , 1977, The New England journal of medicine.

[3]  M. Haussler,et al.  THE ASSAY OF 1α, 25‐DIHYDROXYVITAMIN D3: PHYSIOLOGIC AND PATHOLOGIC MODULATION OF CIRCULATING HORMONE LEVELS , 1976, Clinical endocrinology.

[4]  J. Fischer,et al.  Pseudohypoparathyroidism: Disappearance of the resistance to parathyroid extract during treatment with vitamin D , 1975 .

[5]  M. Haussler,et al.  Filter assay for 1alpha, 25-dihydroxyvitamin D3. Utilization of the hormone's target tissue chromatin receptor. , 1974, Biochemistry.

[6]  A. Moses,et al.  Parathyroid hormone deficiency with Albright's hereditary osteodystrophy. , 1974, The Journal of clinical endocrinology and metabolism.

[7]  C. Pak,et al.  The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. , 1974, The Journal of clinical investigation.

[8]  C. M. Clark,et al.  Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism. , 1972, The Journal of clinical investigation.

[9]  A. Gilman A protein binding assay for adenosine 3':5'-cyclic monophosphate. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Fraser,et al.  Pseudohypoparathyroidism: responsiveness to parathyroid extract induced by vitamin D2 therapy. , 1970, The Journal of clinical endocrinology and metabolism.

[11]  F. Bartter,et al.  Studies in pseudohypoparathyroidism. Two new cases with a probable selective deficiency of thyrotropin. , 1969, The American journal of medicine.

[12]  H. Rasmussen,et al.  The physiological and cellular basis of metabolic bone disease , 1973 .